Future Directions of Proton Beam Radiotherapy for Bone and Soft Tissue Tumors

  • Hirohiko Tsujii
  • Hiroshi Tsuji
Conference paper


Bone and soft tissue tumors frequently recur locally when treated with surgery alone. Therefore, in an effort to improve treatment outcome, combined surgery and radiotherapy has been advocated as an effective modality. However, with conventional radiation, these tumors can usually be given only a moderate dose of radiation with the result that most recur locally. In this regard, proton beam radiotherapy offers potential advantages with respect to dose distribution characterized by Bragg-peak formation, which allows precise delivery of high radiation doses to a tumor while avoiding irradiation to adjacent normal tissues [1, 2].


Soft Tissue Sarcoma Proton Beam Soft Tissue Tumor Local Control Rate Proton Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Munzenrider JE (1987) Clinical results of proton beam radiotherapy in Boston. In: Proc of 8th ICRR (vol 2 ). Taylor and Francis, New York, pp 916–922Google Scholar
  2. 2.
    Austin-Seymour M, Munzenrider JE, Goitein M (1989) Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 70: 13–17PubMedCrossRefGoogle Scholar
  3. 3.
    Suit HD, Mankin HJ, Wood WC (1988) Treatment of the patient with Stage MO soft tissue sarcoma. J Clin Oncol 6: 854–862PubMedGoogle Scholar
  4. 4.
    Suit HD (1982) Soft tissue sarcomas: The role of radiation therapy. Hospital Practice, July, pp 114–120Google Scholar
  5. 5.
    Tepper JE, Suit HD (1985) Radiation therapy alone for sarcoma of soft tissue. Cancer 56: 457–479CrossRefGoogle Scholar
  6. 6.
    Slater JD, McNeese MD, Peters LJ (1986) Radiation therapy for unresectable soft tissue sarcoma. Int J Radiat Oncol Biol Phys 12: 1729–1734PubMedCrossRefGoogle Scholar
  7. 7.
    Greiner RH, Blattmann H, Thum P (1989) Dynamic pion irradiation of unresectable soft tissue sarcoma. Int J Radiat Oncol Biol Phys 17: 1077–1083PubMedCrossRefGoogle Scholar
  8. 8.
    Cummings BJ, Hodson DI, Bush RS (1983) Chordoma: The results of megavoltage radiation therapy. Int Radiat Oncol Biol Phys 9: 633–642CrossRefGoogle Scholar
  9. 9.
    Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW (1973) Chordomas and cartilaginous tumors at the skull base. Cancer 32: 410–420PubMedCrossRefGoogle Scholar
  10. 10.
    Higinbotham NL, Phillips RF, Farr HW, Hustu HO (1967) Chordoma. Cancer 20: 1841–1850CrossRefGoogle Scholar
  11. 11.
    Austin-Seymour M, Urie M, Munzenrider JE, Willett C (1989) Consideration in fractionated proton radiation therapy: Clinical potential and results. Radiother Oncol 70: 13–17Google Scholar
  12. 12.
    Berson AM, Castro JR, Petti P (1988) Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: Lawrence Berkeley Laboratory Experience. Int J Radiat Oncol Biol Phys 15: 559–565PubMedCrossRefGoogle Scholar
  13. 13.
    Linstadt D, Castro JR, Phillips TL (to be published) Neon ion radiotherapy: Results of the phase I—II clinical trials. Int J Radiat Oncol Biol PhysGoogle Scholar
  14. 14.
    Tsujii H (1989) Clinical results of high energy proton radiotherapy at Tsukuba. In: Proc of Int Heavy Particle Therapy Workshop, pp 90–94Google Scholar

Copyright information

© Springer Japan 1992

Authors and Affiliations

  • Hirohiko Tsujii
  • Hiroshi Tsuji
    • 1
  1. 1.Proton Medical Research CenterUniversity of TsukubaTsukuba, IbaragiJapan

Personalised recommendations